Thomas Holm Pedersen

7PUBLICATIONS
44CO-AUTHORS
Neurology and neuromuscular diseasesEcological impacts of climate change and ecological adaptationMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Motor control
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 12, 2025
The Neuromuscular Junction: A Shared Vulnerability in Aging and Disease.

Kathryn R Moss, Fereshteh B Darvishi, Yomna Badawi

|Oct 02, 2025
Chill-tolerant Drosophila species maintain electrogenic muscle membrane potential to resist cold-induced depolarization.

Johannes Overgaard, Jeppe S Bayley, Jacob N Poulsen

|Dec 09, 2024
Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.

Titia Q Ruijs, Catherine M K E de Cuba, Jules A A C Heuberger

|Oct 29, 2024
ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in Rats.

Marianne Skals, Martin Broch-Lips, Martin Brandhøj Skov

|Mar 20, 2024
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.

Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk

|May 22, 2021
Chloride channel inhibition improves neuromuscular function under conditions mimicking neuromuscular disorders.

Thomas Holm Pedersen, William Alexander Macdonald, Martin Broch-Lips

Pageof 2

Frequent Collaborators

2 joint publications

Martin Skov

2 joint publications

Titia Q Ruijs

2 joint publications

Geert Jan Groeneveld

2 joint publications

Jorge A Quiroz